Oncology Molecular Diagnostics Market Analysis Detailed Growth Insights till 2027

The global oncology molecular diagnostics market is forecasted to reach USD 3,568.1 Million by 2027, according to a new report by Reports and Data. The oncology molecular diagnostics market is observing high growth due to the rising occurrences of breast cancer across the globe. Breast cancer is the most common type of cancer occurring in women. There were more than 2 million new cases of breast cancer in 2018. Belgium, Luxembourg, and the Netherlands are the countries with the highest rates of occurrences of breast cancer in the year 2018 across the globe. The global survival rates from the disease vary greatly, ranging from around 80% in North America, Japan, and Sweden to nearby 60% in middle-income nations and lower than 40% in low-income nations. Hence, the implementation of molecular breast diagnostics to screen and detect malignant cells in the human breast is driving the growth of the oncology molecular diagnostics market.

Access Free sample PDF Copy of the Report (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/3714 

Further key findings from the report suggest

  • Cervical cancer is a significant driver of oncology molecular diagnostics market growth as it is one most common causes of cancer in women, with over 500,000 new cases taking place per year across the globe.
  • PCR held a significant market share in 2019, as a real-time PCR offers benefits such as greater sensitivity, quantification ease, precision & reproducibility, better process quality, fast analysis, and lower contamination risk.
  • Hospitals dominated the oncology molecular diagnostics s market in 2019. The factors including well-resourced operating & diagnostic rooms, higher purchasing power, the existence of highly skilled healthcare professionals, and improved health coverage for hospital-based healthcare services from several private and group insurance plans, among others, are responsible for the high market share of hospitals.
  • North America contributed to the largest oncology molecular diagnostics market share in 2019. The market dominance is owing to the higher acceptance of advanced technologies, well-established healthcare diagnostic facilities, the surging incidence of cancer, and the enactment of numerous initiatives for raising awareness about the disease in the region.

The ongoing pandemic is significantly changing the dynamics of the pharma and healthcare sector. Various countries are facing challenges such as shortage of medicines, vaccines, healthcare devices in hospitals. This is expected to open lucrative growth opportunities for market players in the coming years.

For Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/3714 

Competitive Landscape:

The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.

Top Companies Profiled in the Report:

Becton, Dickinson, and Company, Danaher Corporation, Roche Diagnostics, Abbott Laboratories, Cepheid, Qiagen NV, Siemens Healthineers, Bayer AG, Dako, and GE Healthcare, among others.

Browse Full Report Description with Research Methodology, Table of Content and Infographics @ https://www.reportsanddata.com/report-detail/oncology-molecular-diagnostics-market 

Oncology Molecular Diagnostics Market Segmentation:

Cancer Type Outlook (Revenue, USD Million; 2017-2027)

  • Breast Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Blood Cancer
  • Liver Cancer
  • Kidney Cancer

Component Outlook (Revenue, USD Million; 2017-2027)

  • Instruments
  • Reagents
  • Others

Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/3714 

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

Press Release Available @ https://www.reportsanddata.com/press-release/global-oncology-molecular-diagnostics-market 

Explore More Industry Research by Reports and Data:

Next Generation Sequencing Market Size, Growth, Trends and Analysis, By Products and Services (Sample Preparation, Sequencer, Services), By Technology (Sequencing by Synthesis, Ion, SMRT, Nanopore), Application (Diagnostics, Drug Discovery), By End-User (Academia, Clinics), Forecasts To 2027 Download PDF Brochure

Myoelectric Prosthetics Market Analysis, By Product Type (Upper-Extremity Prostheses, Lower-Extremity Prostheses), By Technology (Pattern Recognition, Proportional Control), By End Use (Hospitals, Specialty Orthopaedic Clinics), Forecasts To 2027 Download PDF Brochure

Electroencephalography (EEG) Devices Market Size, Share and Analysis By Product (8-Channel, 21-Channel, 25-Channel, 32-Channel, 40-Channel), By Type (Portable Devices, Standalone Devices), By End-Use (Hospitals, Clinics, Diagnostic Centers, and Others), Forecast To 2017-2027 Download PDF Brochure

Tumor Ablation Market Size, Share and Trends Analysis Report By Treatment (Surgical, Percutaneous, Laparoscopic), By Technology (Cryoablation, IRE, MWA, RFA), By Application (Liver, Lung, Breast, Prostate) and Region, Forecasts to 2026 Download PDF Brochure

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Read the innovative blog at https://www.reportsanddata.com/blogs

Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/videos

 

Back to news